Search results for "Anemia"

showing 10 items of 352 documents

Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial

2014

Blood transfusion and iron chelation currently represent a supportive therapy to manage anemia, vasculopathy and vaso-occlusion crises in Sickle-Cell-Disease. Here we describe the first 5-year long-term randomized clinical trial comparing Deferiprone versus Deferoxamine in patients with Sickle-Cell-Disease. The results of this study show that Deferiprone has the same effectiveness as Deferoxamine in decreasing body iron burden, measured as repeated measurements of serum ferritin concentrations on the same patient over 5-years and analyzed according to the linear mixed-effects model (LMM) (p=0.822). Both chelators are able to decrease, significantly, serum ferritin concentrations, during 5-y…

AdultMalemedicine.medical_specialtyIron OverloadBlood transfusionAdolescentPyridonesAnemiaIronmedicine.medical_treatmentAnemia Sickle CellDeferoxamineIron Chelating AgentsGastroenterologylaw.inventionchemistry.chemical_compoundBasal (phylogenetics)Randomized controlled triallawInternal medicineHumansMedicineBlood TransfusionDeferiproneChildMolecular Biologybusiness.industryCell BiologyHematologyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryDeferoxamineItalychemistrySupportive psychotherapyFerritinsCohortLinear ModelsMolecular MedicineFemalebusinessDeferipronemedicine.drugBlood Cells, Molecules, and Diseases
researchProduct

Unexpected middle cerebral artery peak systolic velocity values in the normal fetal population. Are they a matter of concern?

2018

AbstractObjective: The aim of this study was to investigate in the fetus the relationship between unexpected high middle cerebral artery peak systolic velocity (middle cerebral artery (MCA) peak sy...

AdultMalemedicine.medical_specialtyMiddle Cerebral ArteryPopulationGestational Age030204 cardiovascular system & hematologyUltrasonography PrenatalUmbilical Arteries03 medical and health sciences0302 clinical medicineFetal anemiaPregnancymedicine.arteryInternal medicinemedicineHumansProspective StudieseducationFetuseducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryInfant NewbornObstetrics and GynecologyFetal dopplerAnemiaUltrasonography DopplerFetal DiseasesPediatrics Perinatology and Child HealthMiddle cerebral arteryCardiologyFemalebusinessBlood Flow VelocityThe journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
researchProduct

Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center

2020

Abstract Background Alemtuzumab, is a compound approved for highly active MS, and, in Europe, employed after the use of other disease-modifying treatments (DMTs) with an escalation approach or used as a first therapeutic option. The occurrence of secondary autoimmune adverse events and or infections can differ depending on the employed approach. Objective To evaluate the efficacy and safety of alemtuzumab in real-world MS population that encompassed patients previously treated with other DMTs. Methods 35 patients, treated with alemtuzumab in a single MS Center, were followed for at least 36 months. The study investigated the prevalence of patients reaching the phase of the non-active diseas…

AdultMalemedicine.medical_specialtyMultiple SclerosisEfficacyPopulationDisease03 medical and health sciences0302 clinical medicineInternal medicinePost-hoc analysisOutcome Assessment Health CaremedicineHumansImmunologic Factors030212 general & internal medicineAdverse effecteducationAlemtuzumabeducation.field_of_studybusiness.industryMultiple sclerosisGeneral MedicineMiddle Agedmedicine.diseasePancytopeniaProgression-Free SurvivalNeurologyItalyAdverse eventsDisease ProgressionAlemtuzumabFemaleSettore MED/26 - NeurologiaNeurology (clinical)Autoimmune hemolytic anemiaSafetybusiness030217 neurology & neurosurgerymedicine.drugFollow-Up Studies
researchProduct

Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania.

2011

Background HIV-associated anemia is common and associated with poor prognosis. However, its response to antiretroviral treatment (ART) in rural Africa is poorly understood. Methods HIV-infected adults (≥15 years) who enrolled in HIV care at Haydom Lutheran Hospital in northern Tanzania were included in the study. The effect of ART (zidovudine/stavudine + lamivudine + efavirenz/nevirapine) on HIV-associated anemia was studied in a subset of patients who were anemic at the time they started ART and had a follow-up hemoglobin measurement 12 months later. Pregnant women were excluded from the study, as were women who had given birth within the past 6 weeks. Anemia was defined as hemoglobin <12 …

AdultMalemedicine.medical_specialtyNevirapineAnemiaPopulationVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Communicable diseases: 776HIV InfectionsTanzanialcsh:Infectious and parasitic diseasesHemoglobinsVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Infeksjonsmedisin: 776Risk FactorsInternal medicinemedicineHumanslcsh:RC109-216educationeducation.field_of_studyChi-Square Distributionbusiness.industryMicrocytosisStavudineLamivudineAnemiamedicine.diseaseSurgeryInfectious DiseasesLogistic ModelsAnti-Retroviral AgentsHypochromiaMultivariate AnalysisFemaleHemoglobinbusinessmedicine.drugResearch ArticleBMC infectious diseases
researchProduct

MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease.

1999

The purpose of this study was to evaluate the spectrum of MR findings of the brain in asymptomatic patients affected with thalassemia intermedia or sickle cell-thalassemia disease to prevent brain damage by identifying patients at risk for stroke so that transfusional or pharmacologic treatment could be implemented.Forty-one asymptomatic patients who were younger than 50 years and were affected by minor hemoglobinopathies underwent MR imaging of the brain. Ischemic lesions were classified as small, medium, or large and as single or multifocal. Atrophic changes were graded subjectively as mild, moderate, or severe. A grade of brain damage was assigned to every patient. The frequency and seve…

AdultMalemedicine.medical_specialtyPathologyAdolescentThalassemiaBrain damageAnemia Sickle CellAsymptomaticGastroenterologyCentral nervous system diseaseRisk Factorshemic and lymphatic diseasesInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingChildStrokebusiness.industryVascular diseaseBrainGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingSickle cell anemiaStrokeHemoglobinopathyThalassemiaBrain Damage ChronicFemalemedicine.symptombusinessAJR. American journal of roentgenology
researchProduct

Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: A prospective study

2002

Abstract Background: Most studies of anti-transglutaminase (anti-tTG) assays have considered preselected groups of patients. This study compared the sensitivity, specificity, and predictive value of an immunofluorescence method for anti-endomysial antibodies (EmAs) and two anti-tTG ELISAs, one using guinea pig tTG (gp-tTG) and the other human tTG (h-tTG) as antigen, in consecutive patients investigated for suspected celiac disease (CD). Methods: We studied 207 consecutive patients (99 men, 108 women; age range, 17–84 years) who underwent intestinal biopsy for suspected CD. Patients presented with one or more of the following: weight loss, anemia, chronic diarrhea, abdominal pain, dyspepsia,…

AdultMalemedicine.medical_specialtyPathologyanti-endomysial antibodieSettore MED/09 - Medicina InternaAdolescentTissue transglutaminaseAnemiaClinical BiochemistryGuinea PigsEnzyme-Linked Immunosorbent AssayChronic liver diseaseGastroenterologyCoeliac diseaseEsophagusAntibody SpecificityPredictive Value of TestsInternal medicineImmunopathologymedicineAnimalsHumansanti-transglutaminase; assays; anti-endomysial antibodies; celiac diseaseProspective StudiesProspective cohort studyAgedAutoantibodiesAged 80 and overTransglutaminasesbiologybusiness.industryBiochemistry (medical)HaplorhiniassayMiddle Agedmedicine.diseaseEndomysiumImmunoglobulin ACeliac Diseasemedicine.anatomical_structurePredictive value of testsbiology.proteinFemaleanti-transglutaminasebusiness
researchProduct

Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study

2008

SUMMARYThe aim of this study was to describe the epidemiological and clinical features of tuberculous meningitis in the province of Castellon, Spain. Retrospective analysis was done of all cases attended during the last 15 years. The following groups of variables were assessed: sociodemographic data, medical antecedents, clinical presentation, imaging study results, analyses, cerebrospinal fluid microbiology, treatment, and outcome. Twenty-nine cases were included. Median of age of patients was 34 years, and 17 (59%) were males. HIV infection was present in 15 cases (52%), fever, the most common symptom, occurred in 27 (93%), nuchal rigidity was noted in only 16 (55%), and syndrome of inapp…

AdultMalemedicine.medical_specialtyPediatricsTuberculosisAdolescentFeverEpidemiologyAntitubercular AgentsHIV InfectionsDiseaseTuberculous meningitisInappropriate ADH SyndromeCentral nervous system diseaseCerebrospinal fluidEpidemiologymedicineHumansLungAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryAnemiaRetrospective cohort studyMiddle Agedmedicine.diseaseOriginal PapersMuscle RigiditySurgeryCholesterolTreatment OutcomeInfectious DiseasesSpainTuberculosis MeningealFemaleRadiography ThoracicChest radiographbusinessHypoalbuminemiaEpidemiology and Infection
researchProduct

Erythrocyte deformability in macrocytosis determined by means of ektacytometry techniques

2010

There is little information regarding the behaviour of red blood cell deformability in macrocytosis. We have determined in 114 patients with macrocytosis (MCV > 97 fL) and in 115 age and sex-matched subjects with normocytosis (VCM < 97 fL) erythrocyte deformability by means of ektacytometric techniques (Rheodyn SSD) measuring the erythrocyte elongation index (EEI) at 12, 30 and 60 Pa. Patients with macrocytosis showed statistically higher EEI at all the shear stresses tested when compared with controls (p < 0.001). When patients with macrocytosis were classified according to their main diagnosis as hepatic or renal disease, HIV and miscellaneous, 66.7%, 41.7%, 36.7% and 33.3% of patients, r…

AdultMalemedicine.medical_specialtyPhysiologyBilirubinAnemiaHuman immunodeficiency virus (HIV)NormocytosisMacrocytosismedicine.disease_causeGastroenterologychemistry.chemical_compoundErythrocyte DeformabilityPhysiology (medical)Internal medicinemedicineHumansErythrocyte deformabilityAnemia MacrocyticAlanine aminotransferaseAgedbusiness.industryHematologyMiddle Agedmedicine.diseaseRed blood cellmedicine.anatomical_structurechemistryImmunologyFemaleStress MechanicalCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct

Blood laboratory findings in patients suffering from self-perceived electromagnetic hypersensitivity (EHS)

2009

Risks from electromagnetic devices are of considerable concern. Electrohypersensitive (EHS) persons attribute a variety of rather unspecific symptoms to exposure to electromagnetic fields. The pathophysiology of EHS is unknown and therapy remains a challenge. We hypothesized that some electrosensitive individuals are suffering from common somatic health problems. Toward this end we analysed clinical laboratory parameters including thyroid-stimulating hormone (TSH), alanine transaminase (ALT), aspartate transaminase (AST), creatinine, hemoglobine, hematocrit and c-reactive protein (CRP) in subjects suffering from EHS and in controls that are routinely used in clinical medicine to identify or…

AdultMalemedicine.medical_specialtyPhysiologyBiophysicsThyrotropinAspartate transaminaseHematocritElectromagnetic hypersensitivitychemistry.chemical_compoundElectromagnetic FieldsInternal medicineHypersensitivitymedicineHumansRadiology Nuclear Medicine and imagingIn patientAspartate AminotransferasesAgedInflammationCreatininebiologymedicine.diagnostic_testbusiness.industryLiver DiseasesAlanine TransaminaseAnemiaGeneral MedicineMiddle AgedThyroid DiseasesPathophysiologyC-Reactive ProteinEndocrinologychemistryAlanine transaminaseCreatininebiology.proteinFemalePerceptionmedicine.symptombusinessHormoneBioelectromagnetics
researchProduct

Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia.

1995

Aplastic anemia is occasionally caused by viral hepatitis, hepatitis C virus being the most important factor. Pathogenetically, decreased bone marrow function, abnormalities of the bone marrow microenvironment, and immune-mediated suppression of hematopoiesis are important. Hepatitis C virus infection is associated with a variety of extrahepatic manifestations including autoimmune features like cryoglobulinemia, Sjogren's syndrome, and autoimmune hepatitis. Here we report the case of a 42-year-old man with aplastic anemia due to posttransfusional hepatitis C virus infection associated with cryoglobulinemia and LKM-1 autoantibodies. Following a triple immunosuppressive therapy, there was a c…

AdultMalemedicine.medical_specialtyPhysiologyHepatitis C virusAutoimmune hepatitismedicine.disease_causeBone MarrowInternal medicinemedicineHumansAplastic anemiaAutoantibodiesbusiness.industryGastroenterologyAutoantibodyAnemia AplasticTransfusion ReactionHepatologymedicine.diseaseVirologyCryoglobulinemiaHepatitis Cmedicine.anatomical_structureCryoglobulinemiaImmunologyBone marrowbusinessViral hepatitisDigestive diseases and sciences
researchProduct